Novel insight into mechanisms of cholestatic liver injury.
暂无分享,去创建一个
[1] H. Jaeschke. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[2] R. Straka,et al. Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting , 2011, PloS one.
[3] B. Winklhofer-Roob,et al. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. , 1995, Gastroenterology.
[4] B. Kraupp,et al. In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.
[5] Variant forms of cholestatic diseases involving small bile ducts in adults , 2000 .
[6] H. Popper,et al. Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. , 1972, Gastroenterology.
[7] S. Teng,et al. Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis , 2007, British journal of pharmacology.
[8] D. Billington,et al. Effects of bile salts on the plasma membranes of isolated rat hepatocytes. , 1980, The Biochemical journal.
[9] G. Gores,et al. The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse , 2004, Journal of Pharmacology and Experimental Therapeutics.
[10] C. Benz,et al. Effect of tauroursodeoxycholic acid on bile acid‐induced apoptosis in primary human hepatocytes , 2000, European journal of clinical investigation.
[11] J. Bezerra,et al. Biliary atresia: will blocking inflammation tame the disease? , 2011, Annual review of medicine.
[12] H. Jaeschke,et al. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[13] G. Gores,et al. NF-κB Is Activated in Cholestasis and Functions to Reduce Liver Injury , 2001 .
[14] Jordi Muntané,et al. Mecanismos de lesión hepatocelular , 2007 .
[15] Bryan Goodwin,et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.
[16] P. Fisher,et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. , 2001, Molecular biology of the cell.
[17] H. Jaeschke,et al. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. , 2003, Gastroenterology.
[18] G. Gores,et al. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. , 1994, The Journal of clinical investigation.
[19] D. Mangelsdorf,et al. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. , 2006, Annual review of physiology.
[20] X. Adiconis,et al. Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants: The GOLDN Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[21] H. Denk,et al. Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation. , 1971, Gastroenterology.
[22] Klaas Poelstra,et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid‐induced apoptosis via activation of survival pathways , 2004, Hepatology.
[23] C. Steer,et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. , 1998, The Journal of clinical investigation.
[24] W. Jochum,et al. Characterization of time‐related changes after experimental bile duct ligation , 2008, The British journal of surgery.
[25] K. Iwaisako,et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice , 2011, Hepatology.
[26] C. Trautwein,et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. , 2003, Journal of hepatology.
[27] H. Jaeschke,et al. Oxidative Stress and the Pathogenesis of Cholestasis , 2010, Seminars in liver disease.
[28] J. Schölmerich,et al. Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles , 1984, Hepatology.
[29] G. Gores,et al. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. , 1993, The Journal of clinical investigation.
[30] M. Trauner,et al. Fxr−/− mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids Published, JLR Papers in Press, December 4, 2005. , 2006, Journal of Lipid Research.
[31] B. Balkau,et al. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.
[32] A. Baghdasaryan,et al. Targeting Nuclear Bile Acid Receptors for Liver Disease , 2011, Digestive Diseases.
[33] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[34] G. Gores,et al. Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. , 1995, The American journal of physiology.
[35] C. Trautwein,et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. , 2002, Journal of hepatology.
[36] H. Jaeschke,et al. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. , 1998, Journal of immunology.
[37] R. Sokol,et al. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes , 1993, Hepatology.
[38] H. Jaeschke,et al. Effect of bile duct ligation on bile acid composition in mouse serum and liver , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[39] W. Stremmel,et al. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. , 1998, Journal of hepatology.
[40] Natalie J Torok,et al. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation , 2011, Hepatology.
[41] P. Meier,et al. Parallel decrease of Na+ ‐taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes , 1993, Hepatology.
[42] K. Zatloukal,et al. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. , 2006, The American journal of pathology.
[43] A. Farhood,et al. Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[44] F. Lammert,et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. , 2002, Gastroenterology.
[45] H. Jaeschke,et al. Reduced oncotic necrosis in fas receptor‐deficient C57BL/6J‐lpr mice after bile duct ligation , 2004, Hepatology.
[46] P. Dent,et al. Bile acids as regulatory molecules , 2009, Journal of Lipid Research.
[47] M. Bilzer,et al. Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione. , 1991, Journal of hepatology.
[48] Hartmut Jaeschke,et al. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[49] H. Jaeschke,et al. Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.
[50] S. Bronk,et al. Cytoprotection by fructose and other ketohexoses during bile salt‐induced apoptosis of hepatocytes , 1997, Hepatology.
[51] H. Jaeschke,et al. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. , 2011, The American journal of pathology.
[52] T. Willson,et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Zatloukal,et al. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. , 2009, The American journal of pathology.
[54] J. Boyer,et al. Ursodeoxycholic acid diminishes Fas‐ligand–induced apoptosis in mouse hepatocytes , 2002, Hepatology.
[55] H. Jaeschke,et al. Glutathione peroxidase–deficient mice are more susceptible to neutrophil‐mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress , 1999, Hepatology.
[56] G. Gores,et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. , 2003, The Journal of clinical investigation.
[57] K. Zatloukal,et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.
[58] Lixia Jin,et al. Effect of Culture Time on the Basal Expression Levels of Drug Transporters in Sandwich-Cultured Primary Rat Hepatocytes , 2011, Drug Metabolism and Disposition.
[59] T. Pusl,et al. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1. , 2008, Biochemical and biophysical research communications.
[60] G. Gores,et al. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. , 1995, The Journal of pharmacology and experimental therapeutics.
[61] C. Klaassen,et al. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[62] P. Vandenabeele,et al. Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.
[63] H. Jaeschke,et al. NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[64] Songwen Zhang,et al. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. , 2009, Journal of hepatology.
[65] R. Sokol,et al. Human Hepatic Mitochondria Generate Reactive Oxygen Species and Undergo the Permeability Transition in Response to Hydrophobic Bile Acids , 2005, Journal of pediatric gastroenterology and nutrition.
[66] Hartmut Jaeschke,et al. Apoptosis and necrosis in liver disease , 2004, Liver international : official journal of the International Association for the Study of the Liver.
[67] O. Chazouilleres,et al. Chronic cholestatic diseases. , 2000, Journal of hepatology.
[68] H. Jaeschke,et al. Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo , 2004, Comparative hepatology.
[69] U. Beuers,et al. Bile Acid-induced Apoptosis in Hepatocytes Is Caspase-6-dependent* , 2009, Journal of Biological Chemistry.
[70] C. Steer,et al. Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production , 1998, Molecular medicine.
[71] M. Ebert,et al. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. , 2011, The Biochemical journal.
[72] K. Lindor,et al. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis , 2010, Current gastroenterology reports.
[73] H. Jaeschke,et al. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct–ligated mice , 2003, Hepatology.
[74] P. Galle,et al. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes , 1990, Hepatology.
[75] G. Gores,et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.
[76] G. Gores,et al. The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis* , 2001, The Journal of Biological Chemistry.
[77] J. Maher,et al. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. , 2000, Gastroenterology.
[78] K. Zatloukal,et al. Oncosis represents the main type of cell death in mouse models of cholestasis. , 2005, Journal of hepatology.
[79] H. Jaeschke,et al. Role of neutrophils in acute inflammatory liver injury , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[80] M. Manns,et al. The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis. , 2009, The American journal of pathology.
[81] G. Gores,et al. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. , 2001, The Journal of pharmacology and experimental therapeutics.
[82] G. Dohm,et al. Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle. , 1997, The American journal of physiology.
[83] O. Briz,et al. Bile-acid-induced cell injury and protection. , 2009, World journal of gastroenterology.
[84] D. Brenner,et al. Anti-fibrogenic strategies and the regression of fibrosis. , 2011, Best practice & research. Clinical gastroenterology.
[85] R. Hiipakka,et al. Selective activation of liver X receptor alpha by 6α-hydroxy bile acids and analogs , 2000, Steroids.
[86] A. von Eckardstein,et al. Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[87] L. Schoenfield,et al. Cholestasis induced by sodium taurolithocholate in isolated hamster liver. , 1971, The Journal of clinical investigation.
[88] R. Sokol,et al. Bile acid‐induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition , 2001, Hepatology.